Public Profile

Orion

Orion Corporation, commonly referred to as Orion, is a Finnish pharmaceutical company headquartered in Espoo, Finland. Founded in 1917, Orion has established itself as a key player in the pharmaceutical and biotechnology industry, with a strong presence in Europe and beyond. The company focuses on developing innovative medicines and diagnostic products, particularly in the fields of oncology, pain management, and central nervous system disorders. Orion's core offerings include prescription pharmaceuticals and over-the-counter products, distinguished by their commitment to quality and research-driven development. With a robust pipeline of new therapies and a reputation for excellence, Orion has achieved notable milestones, including successful collaborations and a growing international market presence. As a trusted name in healthcare, Orion continues to advance its mission of improving patient outcomes through science and innovation.

DitchCarbon Score

How does Orion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

70

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Orion's score of 70 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Let us know if this data was useful to you

Orion's reported carbon emissions

In 2023, Orion Corporation reported total greenhouse gas emissions of approximately 431,404,000 kg CO2e, with Scope 1 emissions at about 5,511,000 kg CO2e and Scope 2 emissions at approximately 11,726,000 kg CO2e. The company has set ambitious climate commitments, aiming for a 70% reduction in absolute Scope 1 and 2 emissions by 2030, using 2023 as the baseline year. Additionally, Orion is targeting carbon neutrality in its operations by 2031. Orion's Scope 3 emissions are significant, amounting to approximately 417,464,000 kg CO2e in 2023, highlighting the importance of addressing emissions throughout its supply chain. The company has committed that 78% of its suppliers, based on emissions from purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2029. Overall, Orion's climate strategy includes a long-term goal of achieving net zero emissions by 2050, reflecting its commitment to sustainability and responsible environmental stewardship.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20072008200920132014201520162017201820192020202120222023
Scope 1
3,740,000
0,000,000
0,000,000
0,000,000
0,000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
21,685,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
0,000,000
Scope 3
-
-
-
-
00,000
00,000
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Orion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Orion is in FI, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Orion is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MorphoSys

DE
Other business services (74)
Updated 3 days ago

Pharma Mar

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

STADA Arzneimittel Aktiengesellschaft

DE
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hikma Pharmaceuticals

GB
Pharmaceutical Preparation Manufacturing
Updated 19 minutes ago

Clinigen

GB
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Consort Medical plc

GB
Health and social work services (85)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers